---
category: news
title: "BioXcel Therapeutics Reports First Quarter 2021 Financial Results and Provides Business Update"
excerpt: "Granted FDA Breakthrough Therapy designation for BXCL501 for the acute treatment of agitation associated with dementia; registrational program"
publishedDateTime: 2021-05-10T11:15:00Z
originalUrl: "https://markets.businessinsider.com/news/stocks/bioxcel-therapeutics-reports-first-quarter-2021-financial-results-and-provides-business-update-1030408520"
webUrl: "https://markets.businessinsider.com/news/stocks/bioxcel-therapeutics-reports-first-quarter-2021-financial-results-and-provides-business-update-1030408520"
type: article
quality: 22
heat: 22
published: false

provider:
  name: Business Insider
  domain: businessinsider.com
  images:
    - url: "https://everyday-cc.github.io/ai/assets/images/organizations/businessinsider.com-50x50.jpg"
      width: 50
      height: 50

topics:
  - AI in Healthcare
  - AI

secured: "unxpXaGBaQQPENGqtLZEoyYZZQXKYIz14ib/v/OUtvi0jGI/v65GkPMZsW1yPmpuZOHAv1228eP2VhDSEc7+PB+eIW9XdlGDymV1KPpIiZJ3s21UKJFXy4dKOhTLvcSZ2bghyuFHsdaMcWdKlEQ1ZYroHS59EnK+pAO6EJqvtKXdmDj+AkqlProU6RDgGbqzcNRfTAd6whtVTg+5PT88AzO/4eLRQ8aRBPFEPpEJJKN3PI9aWyibEdVAluBVWq50aWoE79keUtZvwc04LxjbndL/u5cXZIi4J3w4GP5iFUrbjPPZxy9YsCSQZuoAQomlb2zcfEI74MrXrumBTErxy8W8hw12m9upg9qM9aJgd6E=;dh/G83Yj3JF+1xV6sU6PrQ=="
---

